Treatment Outcome and Predictors of Survival in Thai Adult Rhabdomyosarcoma Cases |
Sookprasert, Aumkhae
(Division of Medical Oncology, Internal Medicine Department, Faculty of Medicine, Khon Kaen University)
Ungareewittaya, Piti (Department of Pathology, Faculty of Medicine, Khon Kaen University) Manotepitipongse, Areesa (Division of Medical Oncology, Internal Medicine Department, Faculty of Medicine, Khon Kaen University) Wirasorn, Kosin (Division of Medical Oncology, Internal Medicine Department, Faculty of Medicine, Khon Kaen University) Chindaprasirt, Jarin (Division of Medical Oncology, Internal Medicine Department, Faculty of Medicine, Khon Kaen University) |
1 | Ariel IM, Briceno M (1975). Rhabdomyosarcoma of the extremities and trunk: analysis of 150 patients treated by surgical resection. J Surg Oncol, 7, 269-87. DOI |
2 | Arndt CA, Hawkins DS, Meyer WH, et al (2008). Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer, 50, 33-6. DOI |
3 | Arndt CA, Stoner JA, Hawkins DS, et al (2009). Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol, 27, 5182-8. DOI |
4 | Esnaola NF, Rubin BP, Baldini EH, et al (2001). Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg, 234, 215-23. DOI |
5 | Ferrari A, Dileo P, Casanova M, et al (2003). Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer, 98, 571-80. DOI |
6 | Hawkins WG, Hoos A, Antonescu CR, et al (2001). Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer, 91, 794-803. DOI |
7 | Little DJ, Ballo MT, Zagars GK, et al (2002). Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer, 95, 377-88. DOI |
8 | National Comprehensive Cancer Network. Soft Tissue Sarcoma (Version 1.2015) [Online]. |
9 | Newton WA, Jr., Gehan EA, Webber BL, et al (1995). Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study. Cancer, 76, 1073-85. DOI |
10 | Parham DM, Ellison DA (2006). Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med, 130, 1454-65. |
11 | Sezgin G, Acipayam C, Bayram I, et al (2015). Replacing actinomycin-D with Carboplatin for newly diagnosed rhabdomyosarcoma. Asian Pac J Cancer Prev, 16, 3351-4. DOI |
12 | Simon JH, Paulino AC, Ritchie JM, et al (2003). Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma. Sarcoma, 7, 1-7. DOI |
13 | Stock N, Chibon F, Binh MB, et al (2009). Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis. Am J Surg Pathol, 33, 1850-9. DOI |
14 | Sultan I, Qaddoumi I, Yaser S, et al (2009). Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol, 27, 3391-7. DOI |
![]() |